Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide
Completed · Phase 1 · Has a placebo group
Conditions studied: HIV Infections
In brief
Vaginal microbicides are compounds that may protect women from HIV and other sexually transmitted infections (STIs). This study will determine the safety of the microbicide UC-781 by comparing the effects of keeping the microbicide in the vagina for different lengths of time.
Key facts
- Study ID
- NCT00441909
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 60
- Starts
- 2006-04-01
- Expected to finish
- 2008-04-01
- Last updated by the study team
- 2009-03-05
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.
Where it is running
- Magee-Womens Hospital of University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.